Search Results - "Larché, Jérôme"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    Improved survival of critically ill cancer patients with septic shock by LARCHE, Jérome, AZOULAY, Elie, FIEUX, Fabienne, MESNARD, Laurent, MOREAU, Delphine, THIERY, Guillaume, DARMON, Michaël, LE GALL, Jean-Roger, SCHLEMMER, Benoit

    Published in Intensive care medicine (01-10-2003)
    “…To identify predictors of 30-day mortality in critically ill cancer patients with septic shock. Retrospective study over a 6-year period. Twelve-bed medical…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies by Caillot, Denis, Thiébaut, Anne, Herbrecht, Raoul, de Botton, Stéphane, Pigneux, Arnaud, Bernard, Frédéric, Larché, Jérôme, Monchecourt, Françoise, Alfandari, Serge, Mahi, Lamine

    Published in Cancer (15-12-2007)
    “…BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to…”
    Get full text
    Journal Article
  5. 5

    Organization of the health system in the region to meet the needs of patients Covid long by Breurec, Claire, Larché, Jérôme, Keusch, Vanessa

    Published in Revue de l'infirmière (01-10-2022)
    “…Under the impetus of the Regional Health Agencies, the organization of the health system was redeployed throughout the health crisis linked to Covid-19. Mostly…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Inhibition of Mitochondrial Permeability Transition Prevents Sepsis-Induced Myocardial Dysfunction and Mortality by Larche, Jérome, Lancel, Steve, Hassoun, Sidi Mohamed, Favory, Raphael, Decoster, Brigitte, Marchetti, Philippe, Chopin, Claude, Neviere, Remi

    “…Inhibition of Mitochondrial Permeability Transition Prevents Sepsis-Induced Myocardial Dysfunction and Mortality Jérome Larche, Steve Lancel, Sidi Mohamed…”
    Get full text
    Journal Article
  8. 8

    Co-design of a voice-based app to monitor long COVID symptoms with its end-users: A mixed-method study by Fischer, Aurélie, Aguayo, Gloria, Pinker, India, Oustric, Pauline, Lachaise, Tom, Wilmes, Paul, Larché, Jérôme, Benoy, Charles, Fagherazzi, Guy

    Published in Digital health (01-01-2024)
    “…People living with Long COVID (PWLC), which is still a poorly understood disease, often face major issues accessing proper care and frequently feel abandoned…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Genetic Identification of the Main Opportunistic Mucorales by PCR-Restriction Fragment Length Polymorphism by Machouart, M, Larché, J, Burton, K, Collomb, J, Maurer, P, Cintrat, A, Biava, M. F, Greciano, S, Kuijpers, A. F. A, Contet-Audonneau, N, de Hoog, G. S, Gérard, A, Fortier, B

    Published in Journal of Clinical Microbiology (01-03-2006)
    “…Mucormycosis is a rare and opportunistic infection caused by fungi belonging to the order Mucorales. Recent reports have demonstrated an increasing incidence…”
    Get full text
    Journal Article
  11. 11

    Co-Design of a Voice-Based Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 (UpcomingVoice Study): Protocol for a Mixed Methods Study by Fischer, Aurelie, Aguayo, Gloria A, Oustric, Pauline, Morin, Laurent, Larche, Jerome, Benoy, Charles, Fagherazzi, Guy

    Published in JMIR research protocols (19-06-2023)
    “…Between 10% and 20% of people with a COVID-19 infection will develop the so-called long COVID syndrome, which is characterized by fluctuating symptoms. Long…”
    Get full text
    Journal Article
  12. 12

    Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists by ZANNAD, F, MATZINGER, A, LARCHE, J

    Published in American journal of hypertension (01-07-1996)
    “…Medications given once daily may increase compliance for treatment of hypertension, if the drugs have a prolonged duration of action. The time-effect profiles…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Through/Peak Ratios of Once Daily Angiotensin Converting Enzyme Inhibitors and Calcium Antagonists by Zannad, Faiez, Matzinger, Agnès, Larché, Jérôme

    Published in American journal of hypertension (01-07-1996)
    “…Medications given once daily may increase compliance for treatment of hypertension, if the drugs have a prolonged duration of action. The time-effect profiles…”
    Get full text
    Journal Article